Op-Ed: FDA Commissioner Can’t Ignore Damning New Data On The Dangers Of Mifepristone

The Federalist

U.S. Senator Josh Hawley

The federal government once acknowledged the serious risks of this dangerous drug. When mifepristone was first approved, the government imposed a host of safety measures. Those included prescription by physician only, a requirement that physicians dispense the drug, mandatory follow-up physician visits, reporting of adverse events, and even a “black box” warning alerting women to the drug’s many dangers. And all this was done by the Clinton administration. 

But soon Democrats, joined by Big Pharma, launched a campaign to roll back the safeguards. President Obama reduced the number of required in-person visits and removed the physician-prescription requirement. Then, in an attempt to mask the drug’s true risks, his administration ended the mandatory adverse-event reporting, meaning doctors no longer had to admit when the drug sent their patients to the hospital.

When Joe Biden came to office, the abortion lobby kicked into high gear. The Biden administration eliminated in-person checkups entirely and even did away with the long-standing mandate that physicians dispense the drug in person. Why make these changes? Simple. So mifepristone could be sent through the mail. 

Read full op-ed.